Package Leaflet: Information for the Patient
Candesartan/Hydrochlorothiazide Sandoz 32 mg/12.5 mg Tablets EFG
candesartan cilexetil/hydrochlorothiazide
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
Contents of the pack
The name of your medicine is Candesartan/Hydrochlorothiazide Sandoz. It is used to treat high blood pressure (hypertension) in adult patients. It contains two active substances: candesartan cilexetil and hydrochlorothiazide. These work together to lower your blood pressure.
Your doctor will prescribe candesartan/hydrochlorothiazide if your blood pressure is not controlled enough with candesartan cilexetil or hydrochlorothiazide alone.
Do not takeCandesartan/Hydrochlorothiazide Sandozif:
If you are not sure if you are affected by any of these conditions, consult your doctor or pharmacist before taking candesartan/hydrochlorothiazide.
Warnings and precautions
Tell your doctor or pharmacist before or during treatment with this medicine if:
Your doctor may check your kidney function, blood pressure and the amount of electrolytes (e.g. potassium) in your blood regularly.
See also the information in the section “Do not take Candesartan/Hydrochlorothiazide Sandoz”.
If you are in any of these situations, your doctor may want to see you more often and do some of these tests.
If you are going to have surgery and are taking this medicine, inform your doctor or dentist, as candesartan/hydrochlorothiazide given with some anaesthetics may cause a drop in blood pressure.
Candesartan/hydrochlorothiazide may cause skin sensitivity due to the sun.
Tell your doctor if you experience abdominal pain, nausea, vomiting or diarrhoea after taking Candesartan/Hydrochlorothiazide Sandoz. Your doctor will decide whether to continue treatment. Do not stop taking Candesartan/Hydrochlorothiazide Sandoz on your own.
Children and adolescents
There is no experience with the use of candesartan/hydrochlorothiazide in children and adolescents (under 18 years of age). Therefore, candesartan/hydrochlorothiazide should not be given to children and adolescents.
Tell your doctor if you are an athlete undergoing doping control, as candesartan/hydrochlorothiazide contains an active substance that may give positive results in doping tests.
Other medicines and Candesartan/Hydrochlorothiazide Sandoz
Tell your doctor or pharmacist that you are taking, have recently taken or might take any other medicines.
Candesartan/hydrochlorothiazide may affect the way some medicines work, and some medicines may affect the effect of candesartan/hydrochlorothiazide. If you are taking certain medicines, your doctor may need to do blood tests from time to time.
In particular, tell your doctor if you are taking any of the following medicines, as your doctor may need to change your dose and/or take other precautions:
TakingCandesartan/Hydrochlorothiazide Sandozwith food, drinks and alcohol
Pregnancy and breast-feeding
Pregnancy
You must tell your doctor if you think you are (or might become) pregnant.Your doctor will normally advise you to stop taking candesartan/hydrochlorothiazide before you become pregnant or as soon as you know you are pregnant, and will advise you to take another medicine instead of candesartan/hydrochlorothiazide.
Candesartan/hydrochlorothiazide should not be used during the first three months of pregnancy, and must not be used after the third month of pregnancy, as it may seriously harm your baby.
Breast-feeding
Tell your doctor if you are breast-feeding or about to start breast-feeding. Candesartan/hydrochlorothiazide is not recommended for mothers who are breast-feeding, and your doctor will be able to choose another treatment if you want to start breast-feeding, especially if your baby is newborn or premature.
Driving and using machines
Some patients taking candesartan/hydrochlorothiazide have experienced dizziness or fatigue. If this happens to you, do not drive or use machines.
Candesartan/Hydrochlorothiazide Sandoz contains lactose and sodium
If your doctor has told you that you have an intolerance to some sugars, consult your doctor before taking this medicine.
This medicine contains less than 1 mmol sodium (23 mg) per tablet, i.e. it is essentially “sodium-free”.
Take this medicine exactly as your doctor or pharmacist has told you. If you are not sure, ask your doctor or pharmacist.
It is important to take candesartan/hydrochlorothiazide every day.
The recommended dose is one tablet once a day.
Take the tablets with a glass of water.
Try to take the tablets at the same time each day. This will help you remember to take your dose.
If you take moreCandesartan/Hydrochlorothiazide Sandozthan you should
If you have taken too many tablets, contact your doctor or pharmacist immediately.
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, telephone: 91 562 04 20, indicating the medicine and the amount taken.
If you forget to takeCandesartan/Hydrochlorothiazide Sandoz
Do not take a double dose to make up for forgotten doses. Take the next dose as usual.
If you stop takingCandesartan/Hydrochlorothiazide Sandoz
If you stop taking Candesartan/Hydrochlorothiazide Sandoz, your blood pressure may increase.
Therefore, do not stop taking Candesartan/Hydrochlorothiazide Sandoz without first talking to your doctor.
If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause adverse effects, although not all people suffer from them. It is essential that you know these adverse effects. Some of these adverse effects are a consequence of candesartan cilexetil and others are due to hydrochlorothiazide.
If you notice any of the following adverse effects, stop taking this medicine and seek immediate medical attention:
Also, stop taking Candesartan/Hydrochlorothiazide Sandoz and seek immediate medical attention ifyou develop acute respiratory distress (signs include severe difficulty breathing, fever, weakness, and confusion); this is a very rare adverse effect (may affect up to 1 in 10,000 people).
Candesartan/hydrochlorothiazide may cause a reduction in the number of white blood cells. This can cause a decrease in your resistance to infections, noticing fatigue, infection, or fever. If this happens to you, contact your doctor, who will decide to perform occasional blood tests to check if candesartan/hydrochlorothiazide has caused any effect on your blood (agranulocytosis).
Other possible adverse effects are:
Frequent (may affect up to 1 in 10 people)
Infrequent (may affect up to 1 in 100 people)
Rare (may affect up to 1 in 1,000 people)
Very Rare (may affect up to 1 in 10,000 people)
Unknown (cannot be estimated from available data)
Reporting Adverse Effects
If you experience any type of adverse effect, consult your doctor or pharmacist, even if it is a possible adverse effect that does not appear in this prospectus. You can also report them directly through the Spanish Pharmacovigilance System for Human Use Medicines: www.notificaram.es. By reporting adverse effects, you can contribute to providing more information on the safety of this medicine.
Keep this medicine out of sight and reach of children.
Do not use this medicine after the expiration date that appears on the packaging, label, or blister after CAD/EXP. The expiration date is the last day of the month indicated.
Store in the original packaging to protect it from moisture.
Expiration after opening the HDPE bottle: 3 months.
Medicines should not be thrown away through wastewater or household waste. Deposit the packaging and medicines you no longer need at the SIGRE point in the pharmacy. In case of doubt, ask your pharmacist how to dispose of the packaging and medicines you no longer need. This way, you will help protect the environment.
Composition of Candesartan/Hydrochlorothiazide Sandoz
Product Appearance and Package Contents
Light brown, speckled, oblong, biconvex tablets with the number '32' engraved on one side and scored on both sides.
The score line is for breaking and facilitating swallowing but not for dividing into equal doses.
Al/Al blister pack with desiccant: 7, 10, 14, 28, 30, 56, 60, 90, 98, 100, or 300 tablets.
HDPE bottle with PP cap and desiccant: 56 or 100 tablets.
Only some package sizes may be marketed.
Marketing Authorization Holder and Manufacturer
Marketing Authorization Holder
Sandoz Farmacéutica, S.A.
Centro Empresarial Parque Norte
Edificio Roble
C/ Serrano Galvache, 56
28033 Madrid
Spain
Manufacturer
Lek Pharmaceuticals d.d.
Verovškova 57
1526 Ljubljana
Slovenia
or
Salutas Pharma GmbH
Otto-von-Guericke-Allee 1
39179 Barleben
Germany
or
Lek Pharmaceuticals d.d.
Trimlini 2D
9220 Lendava
Slovenia
or
LEK S.A.
ul. Domaniewska 50 C,
02-672 Warszawa
Poland
This medicine is authorized in the member states of the European Economic Area with the following names:
Germany: Candesartan/HCT Sandoz comp 32 mg/12.5 mg Tabletten
Austria: Candesartan/HCT Sandoz 32 mg/12.5 mg – Tabletten
Belgium: Co-Candesartan Sandoz 32mg/12.5 mg tabletten
Estonia: Prescanden HCT, 32 mg/12.5 mg tabletid
Greece: FYRONEXE PLUS (32+12,5) mg δισκ?α
Italy: CANDESARTAN E IDROCLOROTIAZIDE SANDOZ 32 mg/12.5 mg compresse
Norway: Candemox Comp 32 mg/12.5 mg tabletter
Poland: CANDEPRES HCT, 32 MG + 12.5 MG, TABLETKI
Sweden: Candemox Comp 32 mg/12.5 mg tabletter
Slovenia: Candea HCT 32 mg/12.5 mg tablete
Date of the last revision of this prospectus: February 2025
Detailed and updated information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/
The average price of Candesartan/Hydrochlorothiazide Sandoz 32mg/12.5mg Tablets in October, 2025 is around 20.92 EUR. Prices may vary depending on the region, pharmacy, and whether a prescription is required. Always check with a local pharmacy or online source for the most accurate information.